Norio Itokawa Selected Research

Norio Itokawa Research Topics

Disease

37	Hepatocellular Carcinoma (Hepatoma) 10/2022 - 08/2016
21	Chronic Hepatitis C 06/2021 - 01/2013
16	Liver Cirrhosis (Hepatic Cirrhosis) 07/2022 - 08/2014
16	Fibrosis (Cirrhosis) 01/2022 - 02/2014
11	Non-alcoholic Fatty Liver Disease 07/2022 - 01/2016
9	Liver Diseases (Liver Disease) 01/2022 - 12/2011
7	Neoplasms (Cancer) 01/2022 - 08/2016
6	Infections 06/2021 - 08/2014
5	Edema (Dropsy) 05/2022 - 05/2013
5	Liver Neoplasms (Liver Cancer) 08/2021 - 01/2019
3	Fatigue 06/2022 - 01/2022
3	Ascites 05/2022 - 08/2014
3	Chronic Renal Insufficiency 06/2021 - 03/2018
3	Inflammation (Inflammations) 01/2021 - 10/2016
2	Body Weight (Weight, Body) 07/2022 - 01/2021
2	Type 2 Diabetes Mellitus (MODY) 07/2022 - 01/2021
2	Hypertension (High Blood Pressure) 03/2022 - 01/2022
2	Neoplasm Metastasis (Metastasis) 01/2022 - 04/2021
2	Heart Failure 01/2022 - 07/2021
2	Dyspnea (Shortness of Breath) 01/2022 - 05/2021
2	Sarcopenia 07/2021 - 05/2020
2	Hepatitis C 06/2021 - 02/2019
2	Chronic Hepatitis (Chronic Active Hepatitis) 05/2021 - 04/2019
2	Thrombocytopenia (Thrombopenia) 01/2021 - 01/2015
2	Chronic Hepatitis B 01/2021 - 01/2021
2	Anemia 04/2019 - 09/2017
2	Vitamin D Deficiency 06/2017 - 08/2015
2	Portal Hypertension 02/2014 - 05/2013
1	Carcinoma (Carcinomatosis) 09/2022
1	Hypertriglyceridemia 07/2022
1	Insulin Resistance 07/2022
1	Diarrhea 06/2022
1	Hypothyroidism 06/2022
1	Abdominal Pain (Pain, Abdominal) 03/2022
1	Fever (Fevers) 03/2022
1	Hypotension (Low Blood Pressure) 01/2022
1	Pruritus (Itching) 01/2022
1	Disease Progression 07/2021
1	Pleural Effusion (Pleural Effusions) 05/2021
1	Lung Diseases (Lung Disease) 05/2021
1	Hypergammaglobulinemia (Hyperimmunoglobulinemia) 05/2021
1	Immunoglobulin G4-Related Disease 05/2021

Drug/Important Bio-Agent (IBA)

24	lenvatinibIBA 06/2022 - 01/2019
13	InterferonsIBA 06/2021 - 01/2013
10	Proteins (Proteins, Gene)FDA Link 05/2022 - 07/2009
9	Ribavirin (Virazole)FDA LinkGeneric 04/2019 - 01/2013
8	Bevacizumab (Avastin)FDA Link 10/2022 - 01/2022
8	atezolizumabIBA 10/2022 - 01/2022
8	AlbuminsIBA 01/2022 - 12/2011
7	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2016
6	Antiviral Agents (Antivirals)IBA 06/2021 - 06/2017
6	Vitamin D FDA LinkGeneric 05/2021 - 08/2014
5	Collagen Type IV (Type IV Collagen)IBA 07/2022 - 01/2016
5	BilirubinIBA 01/2022 - 01/2019
5	Sorafenib (BAY 43-9006)FDA Link 08/2021 - 08/2016
5	telaprevirIBA 11/2015 - 07/2014
4	C-Reactive ProteinIBA 10/2022 - 01/2022
4	Alanine Transaminase (SGPT)IBA 07/2022 - 01/2019
4	Hyaluronic Acid (Hyaluronan)IBA 01/2021 - 01/2016
4	hydroxide ionIBA 05/2020 - 08/2014
3	alpha-Fetoproteins (alpha-Fetoprotein)IBA 10/2022 - 04/2021
3	Hemoglobins (Hemoglobin)IBA 07/2022 - 08/2015
3	DiureticsIBA 01/2022 - 06/2016
3	regorafenibIBA 08/2021 - 01/2019
3	SteroidsIBA 05/2021 - 12/2011
3	SofosbuvirIBA 03/2021 - 09/2017
3	wisteria lectinIBA 01/2021 - 05/2018
3	Tolvaptan FDA Link 07/2020 - 06/2016
3	paritaprevirIBA 04/2019 - 12/2017
3	Ritonavir (Norvir)FDA Link 04/2019 - 12/2017
3	ombitasvirIBA 04/2019 - 12/2017
3	Protease Inhibitors (Protease Inhibitor)IBA 11/2015 - 08/2014
2	ledipasvirIBA 03/2021 - 03/2018
2	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2021 - 01/2021
2	lusutrombopagIBA 01/2021 - 12/2018
2	Indicators and Reagents (Reagents)IBA 04/2020 - 01/2020
2	Tyrosine Kinase InhibitorsIBA 01/2020 - 01/2019
2	Nicardipine (Dagan)FDA LinkGeneric 02/2019 - 06/2017
2	Calcifediol (Calcidiol)FDA Link 08/2015 - 12/2014
2	Fluvastatin FDA Link 07/2014 - 01/2013
1	semaglutideIBA 07/2022
1	Ferritins (Ferritin)IBA 07/2022
1	Glucose (Dextrose)FDA LinkGeneric 07/2022
1	Triglycerides (Triacylglycerol)IBA 07/2022
1	Urea (Carbamide)FDA LinkGeneric 05/2022
1	TRK 820IBA 01/2022
1	Opioid Receptors (Opioid Receptor)IBA 01/2022
1	Collagen Type III (Type III Collagen)IBA 01/2022
1	Peptides (Polypeptides)IBA 01/2022
1	Oxygen (Dioxygen)IBA 01/2022
1	Serum AlbuminIBA 08/2021
1	Branched-Chain Amino AcidsIBA 05/2021
1	Transaminases (Aminotransferases)IBA 05/2021
1	Prednisolone (Predate)FDA LinkGeneric 05/2021

Therapy/Procedure

39	Therapeutics 06/2022 - 12/2011
2	Renal Dialysis (Hemodialysis) 06/2021 - 02/2019
2	Transjugular Intrahepatic Portasystemic Shunt 08/2014 - 05/2013
2	Surgical Portasystemic Shunt (Portosystemic Shunt) 08/2014 - 05/2013
1	Immunotherapy 10/2022
1	Critical Care (Surgical Intensive Care) 07/2021